Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action

Conclusion These results project Cbx as a suitable candidate for the inhibition of Aβ 42 aggregation and the therapeutic potential of Cbx against AD can further be studied using in-vivo experiments.
Source: Neurochemistry International - Category: Neuroscience Source Type: research